The relative importance of the sensitivity and the specificity of lateral flow devices (LFDs) depends on the intended […]

I have long had an interest in safe systems and human factors and I am, unfortunately, a perfectionistic […]

Thacker’s point about failure to declare conflicts of interest, and especially financial conflicts, is surely correct1—but what has […]

Meet EUROAPI: Sanofi christens to-be-spun-off drug ingredients business, taps CEO fkansteiner Wed, 01/13/2021 – 07:50

Johnson & Johnson’s COVID-19 vaccine production lags goals as data readout nears: NYT esagonowsky Wed, 01/13/2021 – 09:26

JPM, Day 3: AstraZeneca’s vaccine outlook, Sanofi’s digital pivot, Teva’s post-cutback aims—and more fkansteiner Wed, 01/13/2021 – 09:52

Pharmas pause political contributions in wake of Capitol riots, GOP anti-certification votes bbulik Wed, 01/13/2021 – 10:55

JPM: How did Pfizer up its COVID-19 vaccine capacity? ‘Out of the box manufacturing,’ CEO says chelfand Wed, […]

Updated analysis is from the Phase III IMbrave150 study

First patient in global trial dosed in the UK